Experienced in Piebaldism

Dr. Steven K. Grekin

Advanced Dermatology Of Michigan PC
Warren, MI
Experienced
in Piebaldism
Specialties:Dermatology
Accepting New Patients
Offers Telehealth
OverviewInsuranceLocationsClinical Research

Overview

Steven Grekin is a Dermatologist in Warren, Michigan. Do. Grekin and is rated as an Experienced provider by MediFind in the treatment of Piebaldism. His top areas of expertise are Plaque Psoriasis, Intertrigo, Psoriasis, and Candida Infection of the Skin. Do. Grekin is currently accepting new patients.

His clinical research consists of co-authoring 14 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Piebaldism.

Specialties
Dermatology
Licenses
Dermatology in FL
Hospital Affiliations
Beaumont Hospital - Dearborn
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Priority Health
  •  Blue Cross Blue Shield
  •  McLaren Health
  •  Health Options
  •  UnitedHealthcare
View 2 More Insurances +

Locations

ADVANCED DERMATOLOGY OF MICHIGAN PC
13450 E 12 Mile Rd, Warren, MI 48088
586-759-5525

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Pivotal USA Randomized, Evaluator-blinded, Active-controlled, Multi-center, Split-face Comparison Study of Emervel® Deep Lidocaine Versus Juvederm® Ultra Plus in the Treatment of Moderate to Severe Facial Wrinkles and Folds
A Pivotal USA Randomized, Evaluator-blinded, Active-controlled, Multi-center, Split-face Comparison Study of Emervel® Deep Lidocaine Versus Juvederm® Ultra Plus in the Treatment of Moderate to Severe Facial Wrinkles and Folds
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Drug
Study Drug: Lebrikizumab
Study Phase: Phase 3
An Evaluation of the Safety and Effectiveness of the N-SWEAT Patch for the Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating
An Evaluation of the Safety and Effectiveness of the N-SWEAT Patch for the Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating
Enrollment Status: Completed
Publish Date: September 07, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Multicenter, Randomized, Double Blind, Vehicle-controlled, Phase 2 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Patients With Non-Gorlin High Frequency BCC
A Multicenter, Randomized, Double Blind, Vehicle-controlled, Phase 2 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Patients With Non-Gorlin High Frequency BCC
Enrollment Status: Terminated
Publish Date: May 31, 2023
Intervention Type: Drug
Study Drug: Patidegib
Study Phase: Phase 2
Phase IIb Open-label Trial of SUBA™-Itraconazole in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)
Phase IIb Open-label Trial of SUBA™-Itraconazole in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)
Enrollment Status: Completed
Publish Date: August 05, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of LIPO-202 (Salmeterol Xinafoate for Injection) for the Reduction of Submental Subcutaneous Fat
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of LIPO-202 (Salmeterol Xinafoate for Injection) for the Reduction of Submental Subcutaneous Fat
Enrollment Status: Completed
Publish Date: October 20, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

14 Total Publications

Comparison of Hyaluronic Acid Gel With (HARDL) and Without Lidocaine (HAJUP) in the Treatment of Moderate-To-Severe Nasolabial Folds: A Randomized, Evaluator-Blinded Study.
Comparison of Hyaluronic Acid Gel With (HARDL) and Without Lidocaine (HAJUP) in the Treatment of Moderate-To-Severe Nasolabial Folds: A Randomized, Evaluator-Blinded Study.
Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
Published: May 26, 2018
Similar Doctors
Expertise in
14
conditions
Dr. Iltefat H. Hamzavi
Dermatology
Expertise in
14
conditions
Dr. Iltefat H. Hamzavi
Dermatology

Henry Ford Health System

2799 W Grand Blvd, 
Detroit, MI 
 (10.9 mi)
Languages Spoken:
English, Urdu
See accepted insurances
Accepting New Patients

Iltefat Hamzavi is a Dermatologist in Detroit, Michigan. Dr. Hamzavi and is rated as an Elite provider by MediFind in the treatment of Piebaldism. His top areas of expertise are Hidradenitis Suppurativa, Vitiligo, Hypomelanotic Disorder, and Acne. Dr. Hamzavi is currently accepting new patients.

Expertise in
10
conditions
Dr. Tasneem F. Mohammad
Dermatology
Expertise in
10
conditions
Dr. Tasneem F. Mohammad
Dermatology

Henry Ford Health System

3031 W Grand Blvd, 
Detroit, MI 
 (10.5 mi)
313-916-2600
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Tasneem Mohammad is a Dermatologist in Detroit, Michigan. Dr. Mohammad and is rated as a Distinguished provider by MediFind in the treatment of Piebaldism. Her top areas of expertise are Melasma, Hypomelanotic Disorder, Vitiligo, and Hidradenitis Suppurativa. Dr. Mohammad is currently accepting new patients.

Expertise in
34
conditions
Dr. Richard H. Huggins
Dermatology
Expertise in
34
conditions
Dr. Richard H. Huggins
Dermatology

Henry Ford Health System

6777 W Maple Rd, 
West Bloomfield, MI 
 (21.5 mi)
248-661-4100
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Richard Huggins is a Dermatologist in West Bloomfield, Michigan. Dr. Huggins and is rated as a Distinguished provider by MediFind in the treatment of Piebaldism. His top areas of expertise are Vitiligo, Hidradenitis Suppurativa, Hypomelanotic Disorder, and Keloids. Dr. Huggins is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile